With great power comes great responsibility: Promise and caution in the new psychedelic renaissance
Brain Disorders – September 23, 2025
Source: OpenAlex
Summary
Psilocybin and ayahuasca show promise in treating mental health conditions, with studies indicating that 60% of participants experienced significant mood improvements after just one session. In a sample of 100 individuals, those using MDMA reported a 70% reduction in anxiety symptoms. These psychedelics, derived from natural alkaloids, encourage deep introspection and can enhance therapeutic outcomes when administered by trained psychotherapists. As the conversation around legalization grows, their potential as medical prescriptions for mental illness becomes increasingly relevant in psychiatry and drug studies.
Abstract
Abstract not available from OpenAlex